Abiopharma

🔍 Venturo Brian M (Director)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 1,578,349 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F3
• Acquired 1,578,349 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: G | equity_swap_involved: 0 | shares_owned_after: 1,578,349.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F4
• Holds 5,553,594 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 5,553,594.00 | Footnotes: F1, F1, F1, F5
• Holds 2,871,000 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 2,871,000.00 | Footnotes: F1, F1, F1, F6
• Holds 2,001,900 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 2,001,900.00 | Footnotes: F1, F1, F1, F7
• Holds 5,402,057 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 5,402,057.00 | Footnotes: F1, F1, F1, F8
• Holds 4,990,542 shares of Class B Common Stock (Derivative)
  Date: 2026-08-13 | Code: H | shares_owned_after: 4,990,542.00 | Footnotes: F1, F1, F1, F9

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: The reported transaction represents a gift, for no consideration, of shares of the Issuer's Class B Common Stock, which is exempt from the short-swing profit rule of Section 16 of the Exchange Act, pursuant to Rule 16b-5.
• F3: The reported securities were directly held by Venturo Family 2024 Friends and Family GRAT, of which the reporting person is the sole trustee and beneficiary.
• F4: The reported securities are directly held by Venturo Family 2024 Friends and Family GRAT Remainder Trust, an irrevocable trust with a third-party trustee, of which certain of the reporting person's immediate family members are beneficiaries. The reporting person has the power to remove and replace the trustee. The reporting person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest, if any.
• F5: For clarity, the reporting person previously effected a transfer which resulted in a decrease of the direct ownership of Venturo Family 2024 Friends and Family GRAT and an increase in his direct ownership. The transfer was exempt from reporting under Section 16 of the Exchange Act, pursuant to Rule 16a-13 under the Exchange Act. For avoidance of doubt, the totals reported in Column 5 of Table I reflect ownership after such transfer.
• F6: The reported securities are directly held by the Venturo Family GST Exempt Trust dated June 30, 2023 (the "GST Trust"). The reporting person's spouse is trustee of the GST Trust and minor children are beneficiaries.
• F7: The reported securities are directly held by the reporting person's spouse.
• F8: The reported securities are directly held by the Venturo Family Trust dated June 30, 2023 (the "Family Trust"). The reporting person's spouse is trustee of the Family Trust and his minor children are beneficiaries.
• F9: The reported securities are directly held by West Clay Capital LLC, of which the reporting person is the managing member.